NBIX vs VCTR · P/E 45, rev $2.36B vs P/E 14, rev $893.5M
Neurocrine Biosciences Inc (NBIX) versus Victory Capital Holdings Inc (VCTR) — a side-by-side from cached financials, not a winner call.
Neurocrine Biosciences Inc (NBIX) is a drug manufacturers - specialty & generic company listed on US.
Victory Capital Holdings Inc (VCTR) is a asset management company listed on US.
Latest reported NBIX revenue for 2024-12-31 was $2.36B. Net income was $341.3M. Revenue was up 24.8% from 2023-12-31 to 2024-12-31. NBIX currently screens at market cap $13.21B and trailing P/E 45.2.
Latest reported VCTR revenue for 2024-12-31 was $893.5M. Net income was $288.9M. Revenue was up 8.8% from 2023-12-31 to 2024-12-31. VCTR currently screens at market cap $4.35B and trailing P/E 14.4.
NBIX currently screens at market cap $13.21B and trailing P/E 45.2. VCTR currently screens at market cap $4.35B and trailing P/E 14.4.
Not investment advice. Open the NBIX and VCTR stock pages for the full models.
Not investment advice.